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Abstract: Prader-Willi syndrome (PWS) is a neurodevelopmental disorder of genomic 
imprinting, presenting with a behavioural phenotype encompassing hyperphagia, intellectual 
disability, social and behavioural difficulties, and propensity to psychiatric illness. Research 
has tended to focus on the cognitive and behavioural investigation of these features, and, 
with the exception of eating behaviour, the neural physiology is currently less well 
understood. A systematic review was undertaken to explore findings relating to neural 
structure and function in PWS, using search terms designed to encompass all published 
articles concerning both in vivo and post-mortem studies of neural structure and function in 
PWS. This supported the general paucity of research in this area, with many articles reporting 
case studies and qualitative descriptions or focusing solely on the overeating behaviour, 
although a number of systematic investigations were also identified. Research to date 
implicates a combination of subcortical and higher order structures in PWS, including those 
involved in processing reward, motivation, affect and higher order cognitive functions, with 
both anatomical and functional investigations indicating abnormalities. It appears likely that 
PWS involves aberrant activity across distributed neural networks. The characterisation of 
neural structure and function warrants both replication and further systematic study. 
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1. Introduction 
Prader-Willi Syndrome (PWS) is a neurodevelopmental disorder of genomic imprinting resulting in 
the lack of paternal expression of maternally-imprinted genes at chromosomal locus 15q11-13, most 
commonly caused by a deletion of this region on the paternal chromosome (ca. 70% cases), maternal 
uniparental disomy (UPD; ca. 25% cases), or a defect in the regulating imprinting centre (ca. 3%–5% 
cases). Affecting around one in 25,000–29,000 live births, PWS presents with a characteristic, although 
variable, phenotype [1,2]. Most prominently, infants are born with severe hyptonia and show an initial 
failure to thrive, which is replaced during preschool years by an insatiable appetite, necessitating external 
restriction of food and commonly resulting in life-threatening obesity if such restrictions are not in place. 
Relative growth and sex hormone deficiencies mean that short stature is common and sexual 
development disrupted, and a typical facial phenotype is often present. Beyond these obvious effects, 
such hormonal deficiencies can also be expected to influence neural development. The role of growth 
hormone in the brain is not fully understood, but receptors are found throughout the brain and research 
has suggested potential effects of growth hormone supplementation in PWS on behaviour and cognition [3]. 
Similarly, although not the sole influence of sex on neural structure and function, sex hormones play an 
important role in sexual differentiation during brain development [4]. The treatment of these deficiencies, as 
has become common in PWS, may again alter the course of brain development. 
The characteristics described thus far strongly suggest a disorder of hypothalamic control. However, 
in addition to these core features, PWS is typically associated with mild to moderate intellectual 
disability, a high pain threshold and a variable range of social and behavioural difficulties, including 
temper outbursts,need for routine, skin picking, repetitive and ritualistic behaviours, and poor social 
functioning, as well as a propensity to psychiatric disturbance [5–7]. Thus, the effects of the genetic 
aberration resulting in PWS are diverse and are likely to involve a widespread atypical pattern of 
development of the brain. While the characterisation of PWS at the cognitive and behavioural levels has 
received considerable attention, with the exception of the eating behaviour, much less is known about 
the neural endophenotype. Such behaviours are also likely to be shaped and maintained by 
environmental factors, however, a greater elucidation of the neural underpinnings of these behaviours 
would aid our understanding of the likely complex biopsychosocial interactions that result in such 
behaviours and why they persist over time. Such knowledge will lead ultimately to the development of 
treatments, pharmacological or psychological, which could have a significant effect on quality of life for 
individuals with PWS and those who support them. 
Increased understanding of the brain in PWS will also offer insight into the role of genomic imprinting 
in the brain and the purposes this may serve within the typically-developing population, with the paternal 
contribution disrupted in PWS, as well as gene dosage effects of the maternal contribution in UPD. 
Angelman’s syndrome (AS) is the sister imprinting disorder of PWS, arising from the lack of maternal 
expression of paternally-imprinted genes located at the same critical region on chromosome 15, and 
presents with a different phenotype including greater severity of intellectual disability, seizures, ataxia 
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and speech impairment. Perhaps the most prominent evolutionary theory of genomic imprinting 
discussed in relation to PWS is kinship theory, which suggests that gender of origin imprinted genes that 
are only expressed from the paternal allele are particularly involved in growth and attainment of 
resources, including in placental functioning prenatally, whilst alleles of genes that are only expressed 
from the maternal line appear more integral to balancing the needs of the offspring with costs to the 
matrilineal relatives [8]. Better knowledge about the effects of aberrant genomic imprinting on the PWS 
neural endophenotype may help support or refute these claims. 
2. Literature Search 
A systematic review was undertaken to explore findings relating to neural structure and function in 
PWS, using the search terms and inclusion pathway illustrated in Figure 1 below. The PubMed and Web 
of Knowledge databases were searched using a search term designed to identify all published articles 
(including conference abstracts) concerning both in vivo and post-mortem studies of neural structure and 
function in PWS. All articles written in English and reporting an original study of neural structure or 
function in PWS were included and review articles and reference lists were searched for additional 
relevant articles not already identified. Articles reporting electroencephalography (EEG) solely in 
relation to sleep stages or apnoea were excluded, since they tended to describe sleep stage duration only, 
as were articles solely reporting haemorrhage, stroke or cerebral thrombosis. Most of the latter reports 
were case studies and such insult to the brain was felt to be unlikely to be highly informative to an 
understanding of PWS itself, but more related to the effects of these other conditions. As such, they were 
beyond the scope of this review. An initial round of screening excluded articles according to title or 
abstract which clearly did not meet the inclusion criteria, before eligibility of remaining articles was 
assessed. This supported the general paucity of research in this area, returning only 66 relevant unique 
articles, including case studies and conference abstracts. 
Relevant articles were subdivided according to whether they concerned neural structure at the 
macrostructural level, neurochemical investigations and neuroanatomy at the cellular level, neural 
function in relation to eating behaviour or neural function relating to other aspects of the PWS 
phenotype. This further highlighted that neural structure and function have typically been considered in 
isolation, with the majority of functional investigations concerning eating behaviour in PWS and over 
half of the structural studies reporting case studies or investigations of the pituitary gland alone. Further 
details of all articles, including brief summaries of methodologies, sample characteristics and key 
findings can be found in Tables 1–3. 
3. Anatomical Structure of the PWS Brain 
Given the many features of PWS indicative of hypothalamic dysfunction, a significant proportion of 
studies regarding the anatomy of the brain in PWS have focused on the hypothalamic-pituitary area. 
Findings have varied, and, while indicating possible abnormalities, neither evidence for hypothalamic 
pituitary anomaly nor the form of any defect is conclusive. Two case studies of children with PWS 
reported normal pituitary evaluations using magnetic resonance imaging (MRI) [9,10], while another 
found a reduced pituitary diameter but no further neuropathologies [11]. Retrospectively evaluating the 
MRIs of 91 children with PWS, Iughetti et al. (2008) reported decreased pituitary height in 45 and 
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absence of posterior pituitary bright spot in six [12], while Tauber et al. (2000) also reported pituitary 
hypoplasia in 60% of a retrospective sample of 16 children with MRI available, regardless of whether 
or not they had received GHT [13]. Grugni et al. (2000) reported 10 of 17 PWS participants presenting 
with pituitary hypoplasia and three with empty sella, with only four showing a normal pituitary gland [14]. 
However, these studies did not directly compare individuals with PWS to control samples. 
 
Figure 1. Article identification process for systematic literature review of neural structure 
and function in Prader-Willi syndrome (PWS). Literature search was carried out on 28 April 
2015. Note that subcategories (e.g., case studies/series) within each main category (e.g., 
structural anatomy) are not mutually exclusive and references may be featured in more than 
one subcategory. *: One study features in both categories.
Task-based
n = 5
Search terms:
“Prader Willi” OR “Prader-Willi” OR “Prader Labhart Willi” OR “Prader-Labhart-Willi”
AND
post-mortem OR neuroimaging OR "brain imaging" OR "magnetic resonance imaging" OR fMRI OR MRI OR "diffusion 
tensor imaging" OR DTI OR "positron emission tomography" OR PET OR "magnetic resonance spectroscopy" OR MRS 
or magnetoencephalography OR MEG OR electroencephalography OR EEG OR "functional near-infrared 
spectroscopy" OR fNIRS
PubMed search returned 123 
results
Web of Knowledge search 
returned 261 results
Total after exclusion on 
basis of title or abstract 
n = 63
Total after exclusion on 
basis of full article
n = 50
Additional articles identified 
from reference list search
n = 16
Total of unique results
n = 267
Total number of relevant articles identified
n = 66
Structural anatomy 
n = 36 * Function relating to 
eating behaviour
n = 9
Case 
studies/series
n = 10
Function not relating to 
eating behaviour
n = 12 *
Investigation of 
pituitary only
n = 7
Inclusion criteria:
• Written in English
• Human study
• Original research (not review)
• Reports aspect of neural function or 
structure in PWS brain
Exclusion criteria
• Poster abstract reporting same results 
as full article.
• EEG only in relation to exploration of 
sleep stages or apnoea.
Resting 
state
n = 7Primarily 
investigation of 
epilepsy in PWS
n = 8
Neurochemical 
investigations
n = 12
n = 42
• Not about PWS = 1
• Not about brain in PWS = 1
• Only about cerebral thrombosis/haemorrhage = 3
• Poster with duplicate poster or full article 
reporting same results = 7
• Neither abstract nor paper accessible = 1
• Not in English = 12
• Not about PWS = 107
• Not human research = 7
• Not about brain in PWS = 30
• Not original research  article (review, comments 
or patent) =  35
• EEG regarding sleep stages/apnoea only = 12
• Not enough information = 1
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Table 1. Studies reporting macrostructural anatomy in PWS. 
Author Methods Sample Key findings 
Cacciari et al. 1990 [9] MRI—pituitary evaluation only 1 PWS patient in larger study of 101 patients (15 y) No abnormality found. 
Crino et al. 2008 [10] MRI—pituitary evaluation only 8 y old male with PWS No abnormality found. 
Fan et al. 2005 [15] 
Retrospective case reviews of 
available MRI data 
MRI available for 9/10 patients with seizures from total PWS 
sample of 56 (31 males, 1–37 y) 
MRI normal for 8/9; haemorrhage in 1/9. 
Gilboa & Gross-Tsur 2013 [16]
Retrospective case reviews of 
available imaging data for patients: 
MRI, CT, ultrasonography 
Imaging data available for 59 of 125 PWS patients (50% 
male, 1 month–48 y): MRI for 30; CT for 17; 
ultrasonography for 12 
Abnormalities in 20/59, incl. 4/5 with epilepsy: including ventriculomegaly (3/59); 
thalamic abnormalities (3/59); partial corpus callosum agenesis (3/59); disturbed 
myelination (3/59); partial empty sellar (1/59). 
Grugni et al. 2000 [14] MRI—pituitary only. 17 PWS patients (9 males, mean 20 y) Pituitary hypoplasia (10/17); empty sella (3/17). 
Hashimoto et al. 1998 [17] MRI and 1H-MRS 
5 PWS patients (2 males, 1–14.5 y) 
37 control infants and children (1–15 y) 
Abnormalities in 5/5: mild ventriculomegaly (4/5); frontal cortical atrophy (3/5); small 
brainstem (1/5); delayed myelination (1/5). 
Metabolite abnormalities: Reduced NAA peak in; NAA:Choline and NAA:Creatine 
ratios tended to be lower in PWS group with a signification relationship between these 
metabolite rations and developmental level. 
Hayashi et al. 1992 [18] Post-mortem 6 month old female with PWS 
No pituitary abnormality; abnormalities of cortical gyrification, cerebellar white matter 
and dentate gyrus. 
Honea et al. 2012 [19] MRI 
23 participants with PWS (8 males, 10–39 y) 
25 typically-developing control participants (11 males,  
10–48 y) 
Deletion vs. UPD: reduced grey matter volume in PFC & temporal cortex and reduced 
white matter volume in parietal cortex in deletion; reduced grey and white matter 
volume in OFC and limbic cortex in UPD. 
Iughetti et al. 2008 [12] 
Retrospective case reviews of 
available MRI data 
91 children with PWS (49 males, 0.7–16.8 y) 
Abnormalities in 61/91: reduced pituitary height (45/91); absence of posterior pituitary 
bright spot (6/91); ventriculomegaly (8/91); thin corpus callosum (2/91). 
Kumada et al. 2005 [20] 
Retrospective case reviews of 
available MRI data 
Imaging data available for 3/4 patients with PWS and 
epilepsy (1 males, 3–12 y) in larger study of chromosomal 
abnormalities and epilepsy 
Cerebral atrophy in 1/3. 
Leonard et al. 1993 [21] MRI 
4 children with PWS (3 males, 3–10 y) 
6 with AS (3 males, 2–7 y) 
Abnormality in sylvian fissure of 1/4 PWS children (unilateral), but 6/6 AS (2 bilateral, 
4 unilateral). 
Linnemann et al. 1999 [11] MRI case study 6 y old male with PWS Small flat pituitary; no further abnormalities. 
Lukoshe et al. 2013 [22] MRI 
20 children with PWS (9 males, 6–17 y) 
11 sibling control participants (8 males,7–15 y) 
Significantly reduced brainstem volume in PWS group compared to control group; trend 
to reduced white matter volume and total cortical surface area in PWS. 
Greater ventriculomegaly and surface CSF in UPD compared to deletion subtypes. 
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Table 1. Cont. 
Author Methods Sample Key findings 
Lukoshe et al. 2014 [23] MRI 
24 children with PWS (9 males, 6–18 y) 
11 sibling control participants (8 males,7–15 y) 
Decreased cortical complexity in four clusters in frontal, temporal and parietal lobes. 
Cortical complexity positively correlated with IQ. 
Greater cortical thickness and lower cortical complexity in some clusters in UPD. 
Mantoulan et al. 2011 [24] MRI 
9 PWS teenagers (6 males, 12.7–18.6y, mean 16.4 y) 
9 typically developing young adults (6 males, mean 21.2 y) 
No abnormalities found. 
Maski et al. 2009 [25] 
Retrospective case reviews of 
available “neuroimaging” data: 
unspecified modality 
Imaging data available for 14/21 PWS patients with seizures Unspecified non-focal abnormalities in 3/14. 
Miller et al. 1996 [26] MRI 
15 individuals with PWS (6 males, 2–28 y) 
16 age- & sex-matched group with isolated growth hormone 
deficiency (10 males, 3–14 y) 
49 age-matched typically-developing controls from previous 
literature (1–29 y) 
No significant difference in pituitary height. 
Posterior pituitary bright spot absent in 3/15 PWS participants and reduced in 1/15. 
Miller et al. 2006 [27] MRI 
17 PWS participants (11 males, 4–39 y) 
18 individuals with early-onset morbid obesity (EMO)  
(9 males, 4–22 y) 
21 typically-developing siblings (8 males, 3.5–43 y) 
White matter abnormalities in 6/8 adults with PWS and 5 participants with EMO, but 
0/9 children with PWS and none in typically-developing controls participants. 
Miller et al. 2007 [28] MRI 
27 PWS participants (16 males, 3 m–39 y) 
13 EMO participants (4 males, 4–16 y) 
26 typically developing siblings (10 males,  
2 m–43 y). 
Incomplete insular closure in PWS, compared to both sibling and EMO control groups. 
Miller et al. 2007 [29] MRI 
20 PWS participants (12 males, 3 m–39 y) 
16 individuals with EMO (8 males, 15 m–22 y) 
21 typically-developing siblings (10 males, 2–43 y) 
Abnormalities in all 20 PWS participants: ventriculomegaly (20/20); incomplete closure 
of the insula (13/20); sylvian fissure polymicrogyria (12/20); decreased parietal-
occipital volume (10/20). None of these abnormalities in either EMO or sibling control 
groups. 
Miller et al. 2008 [30] MRI—pituitary evaluation only 
27 individuals with PWS (16 males, 3 m–39 y) 
16 individuals with EMO (6 males, 4-22 y) 
25 typically-developing siblings (10 males, 2–43 y) 
Pituitary abnormalities in 20/27 PWS, 10/16 EMO & 2/25 controls. Abnormality not 
specific to PWS. 
Miller et al. 2009 [31] MRI 
16 PWS participants (10 males, mean 16.53 y) 
12 EMO participants (4 males, mean 9.25 y) 
15 typically-developing siblings (5 males, mean 12.08 y) 
Reduced cerebellar volume and cerebellar/cerebral ratio in PWS and EMO compared to 
sibling group, but no difference between PWS and EMO. 
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Table 1. Cont. 
Author Methods Sample Key findings 
Ogura et al. 2011 [32] MRI 
12 adults with PWS (6 males, 19–31 y) 
13 age- & sex-matched controls (6 males, 19–29 y) 
Reduced total brain, grey matter and white matter volume, and focally reduced OFC and 
somatomotor area volume in PWS. 
Stevenson et al. 2004 [33] MRI and post-mortem 
Post-mortem: 5 month, 9 month, & 3.5 y old with PWS (2 males) 
MRI: 9 month old female with PWS 
Cortical grey & white matter abnormalities in 3/4; midbrain, hindbrain & cerebellar 
abnormalities in 1/4; normal in 1/4. 
Takeshita et al. 2013 [34] 
Retrospective case reviews of 
available imaging data for patients: 
MRI, CT 
MRI available for 9/31 PWS patients with seizures (6 males, 
neonatal–3 y) 
Diffuse atrophy in 1/9, but appears to have followed some injury to the brain of 
undisclosed nature. 8/9 within normal limits. 
Tauber et al. 2000 [13] 
Retrospective case reviews of 
available MRI data—pituitary only 
MRI for 16/28 with PWS (mean 11.8 y) Pituitary hypoplasia in 10/16. 
van Nieuwpoort et al. 2011 [35] MRI—pituitary only 
15 adults with PWS (4 males, 19.2–42.9 y) 
14 typically-developing siblings (7 males; 17.5–41.3 y) 
Reduced anterior pituitary size in 12/15 adults with PWS compared to sibling group. 
Vendrame et al. 2010 [36] 
Retrospective case reviews of 
available MRI data 
Imaging available for 20/30 PWS patients with seizures (6 males, 
4–21 y) 
Abnormalities in 5/20: ventriculomegaly (4/20); diffuse cortical atrophy (1/20). 
Verrotti et al. 2015 [37] 
Retrospective case reviews of 
available imaging data for patients: 
MRI, CT 
Imaging data available for 35/28 PWS patients with seizures 
(22 males, seizure onset 2 days–11 y, age at imaging 
evaluation unspecified): MRI for 25; CT for 10 
Abnormalities in 11/35: ventriculomegaly (5/35), cortical atrophy (4/35), corpus 
callosum hypoplasia (1/35), periventricular leukomalacia (1/35). 
Yamada et al. 2006 [38] DTI 
8 participants with PWS (6 males, 8–29 y) 
8 age- & sex-matched typically-developing controls (6 males, 
8–29 y) 
Atypical diffusivity indicating abnormalities of frontal white matter, posterior limb of 
internal capsule, and splenium of corpus callosum. 
Yoshii et al. 2002 [39] MRI case study 40 week old female with PWS 
Abnormal gyrification and cortical grey-white matter boundaries; partially uncovered 
right insula. 
AS: Angelman’s syndrome; BMI: body mass index; CSF: cerebrospinal fluid; CT: computerised tomography; DTI: diffusion tnsor imaging; EMO: early-onset morbid 
obesity; 1H-MRS: proton magnetic resonance spectroscopy; MRI: magnetic resonance imaging; IQ: intelligence quotient; m: months; NAA: N-acetylaspartate;  
OFC: orbitofrontal cortex; PFC: prefrontal cortex; PWS: Prader-Willi syndrome; UPD: uniparental disomy; y: years.  
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Table 2. Studies reporting neural function in PWS at the macrostructural level. 
Study Methods Sample Mai findings 
Akefeldt et al. 1997 [40] EEG: Auditory brainstem response. 
7 participants with PWS (6 males, 4–25 y) 
7 control participants with intellectual disability (5 males,  
5–26 y) 
Atypicalities of auditory brainstem response compared to control group and laboratory 
reference values. 
Dimitropoulos & Schultz 
2008 [41] 
fMRI: response to high vs. low 
calorie food images. 
9 participants with PWS (3 males, 8–38 y) 
10 IQ and BMI matched control participants (4 males, 19–29 y) 
Increased amygdala, hypothalamus, insula and OFC activity when fasted in response to 
images of high vs. low calorie foods. 
Halit et al. 2008 [42] EEG: face and gaze perception. 
8 adults with deletion subtype of PWS(20–53 y) 
8 with UPD subtype of PWS (19–52 y) 
Behavioural performance impaired for both genotypes, but ERP showed increased 
impairment in the deletion group: N170 amplitude larger for averted vs. direct gaze and 
inverted vs. upright faces in UPD, but not deletion group. 
Hinton et al. 2006 [43] 
PET: pre- and post-meal (400 &  
1200 kcal) response to food images. 
13 participants with PWS (22–42 y) 
Increased activity in medial OFC, temporal cortex and PFC usually found not seen in 
PWS following meals when viewing food images. 
Hinton et al. 2006 [44] 
PET: response to high and low 
incentive food images. 
13 participants with PWS (22–42 y) 
Increased activation of amygdala and medial OFC typically seen in response to high vs. 
low incentive foods not found. 
Holsen et al. 2006 [45] 
fMRI: pre- and post-meal (500 kcal) 
response to food images and control 
animal images 
9 participants with PWS (1 male, mean 14.7 y) 
9 age matched typically-developing controls (3 males, mean 
14.4 y) 
PWS group showed reduced activity when viewing food vs. animal images in medial 
PFC and OFC in pre-meal condition than control group and greater medial PFC, insula, 
parahippocampal gyrus and amygdala activity in post-meal condition. 
Holsen et al. 2009 [46] 
fMRI: pre- and post-meal (500 kcal) 
responses to food images and control 
animal images. 
9 participants with PWS deletion subtype (2 males; mean 24.4 y) 
9 participants with PWS UPD subtype (3 males; mean  
20.8 y) 
9 healthy weight controls (3 males; mean 23.6 y) 
Both PWS subtypes showed atypical response in both pre- and post-meal conditions 
compared to control group. 
Deletion vs. UPD: greater activity in deletion group in frontal/limbic areas, especially 
medial PFC and amygdala, in both pre- and post-meal conditions; greater activity in 
dorsolateral PFC and parahippocampal gyrus in UPD group in post-meal condition only. 
Holsen et al. 2012 [47] 
fMRI: pre- and post-meal 500 kcal) 
responses to food images and control 
animal images. 
14 participants with PWS (2 males, mean 23.3 y) 
14 BMI & age-matched control participants (5 males; mean 
25.0 y) 
15 healthy weight age-matched controls (6 males; mean 23.1 y) 
Pre-meal: increased activity when viewing food vs. non-food images in nucleus 
accumbens and amygdala in PWS than either control group control group, and lower in 
hypothalamus and hippocampus. 
Post-meal: increased activity in hypothalamus, amygdala and hippocampus in PWS than 
either control group, but higher dorsolateral PFC and OFC in obese group not seen in 
PWS or healthy weight control group. 
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Table 2. Cont. 
Study Methods Sample Mai findings 
Key & Dykens 2008 [48] 
EEG: N1 & P3 ERP response to food 
images according to 
categorisation/discrimination of food 
composition and quality. 
9 participants with deletion subtype of PWS (2 males,  
mean 22.9 y) 
8 participants with UPD subtype of PWS (3 males, mean 22.4 y) 
9 age-matched control participants (4 males, mean 21.7 y) 
N1 ERP suggested deletion group early processing by categorising mainly according to 
quantity, whilst UPD did so by quality and suitability for consumption more similarly to 
the control group. 
Later P3 response showed deletion group could discriminate foods by combinational 
suitability, but this later processing response was greater than that seen in UPD. Later P3 
motivational processing of food images not seen in control group. 
Kim et al. 2006 [49] Resting-state PET while fasted. 
16 children with PWS (9 males, mean 4.2 y) 
7 typically-developing siblings/relatives (4 males,  
mean 4.0 y) 
PWS group showed decreased metabolism in right superior temporal gyrus and left 
verebellar vermis, and increased metabolism in right OFC, bilateral medial PFC, right 
inferior and left superior frontal cortex, bilateral ACC, right temporal pole and left uncus. 
Klabunde et al. 2015 [50] 
fMRI: sessions where participants 
engaged in skin picking compared to 
sessions where they did no. 
17 participants with PWS (11 males, mean 15.7 y) 
2 main clusters showing greater activation during skin picking: right ACC & right middle 
frontal gyrus; primary somatosensory cortex, left inferior parietal lobule, supplementary 
motor area, left middle frontal gyrus and right posterior insula. 
Self-injury trauma scale scores negatively correlated with right insula and left precentral 
gyrus activity. 
Mantoulan et al. 2011 [24] Resting-state PET 
9 PWS teenagers (6 males; 12.7–18.6y, mean 16.4 y) 
9 typically developing young adults (6 males; mean 21.2 y) 
Hypoperfusion in PWS, most strongly in ACC and superior temporal regions, but also in 
right orbitofrontal gyrus and postcentral gyrus. 
Positive correlations between Child Behaviour Checklist (CBCL) scale scores and rCBF 
in ACC (activity, social, & attention scales), superior temporal gyrus (attention & social 
scales), and superior frontal gyrus (activity scale). Negative correlation between rCBF in 
ACC and CBCL depression scale score. 
Miller et al. 2007 [51] 
fMRI: response to food images 
following glucose load. 
8 participants with PWS (6 males, mean 25 y) 
8 typically-developing siblings (4 males, mean 27 y) 
Significantly increased activity ventromedial PFC in PWS group when viewing food 
images following glucose load. 
Ogura et al. 2013 [52] Resting state PET 
12 participants with PWS (6 males, 19–31 y) 
13 age- & gender-matched controls (6 males, 19–29 y) 
Decrease metabolism in PWs group in the lingual gyri, cerebellum, right thalamus and 
left insula. Increased metabolism in bilateral angular and inferior frontal gyri and left 
middle frontal gyrus. 
Negative correlation between questionnaire score of eating severity and rCBF in  
left insula. 
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Table 2. Cont. 
Study Methods Sample Mai findings 
Pujol et al. 2014 [53] Resting state fMRI 
24 adults with PWS (12 males, mean 26.3 y) 
20 adults with Down’s syndrome (10 males, mean 24.5 y) 
20 adults with William’s syndrome (11 males, mean 25.2 y) 
80 young adults (45 males, mean 26.4 y) 
71 children (30 males, mean 9.6 y) 
53 older adults (24 males, mean 67.4 y) 
Young adults showed sensorimotor system activity positively correlating with motion, 
suggesting system specific effects. Seen to some extent in children and older adults but 
also wider effects of motion. 
Greater motion in genetic disorders, and specific motion-connectivity correlations: PWS 
group shoed mostly frontal and temporal lobe correlations with motion, but also 
significant in the dorsal ACC; in Down’s syndrome group was with anterior and dorsal 
regions; and in William’s syndrome were diffuse correlations across grey matter voxels. 
Shapira et al. 2005 [54] fMRI: before and after glucose load. 3 participants with PWS (1 male, 25–38 y) 
Delay in activation of brain areas associated in satiety response in previous study of 
participants without PWS, including hypothalamus, insula, ventromedial PFC and 
nucleus accumbens following oral glucose load. 
Stauder et al. 2002 [55] 
EEG: P3 ERP response to visual and 
auditory oddball tasks. 
10 adults with PWS (5 males, mean 30.8 y) 
10 typically-developing controls (3 males, mean 23.2 y) 
Markedly decreased P3 response in both visual and auditory tasks in PWS compared to 
control group, and most strongly for the auditory task. 
Stauder et al. 2005 [56] 
EEG: N200 and P300 ERPs during 
response inhibition on Go-Nogo task.
11 participants with deletion subtype of PWS (7 males,  
mean 26.7 y) 
11 participants with UPD subtype of PWS (4 males,  
mean 27.7 y) 
11 typically-developing control participants (6 males,  
mean 27.3 y) 
Behavioural task performance poorer for both PWS groups compared to control group. 
N200 amplitude didn’t show normal peak in either PWS group, suggesting impaired 
early modality specific inhibition in both UPD and deletion, but only UPD group showed 
impaired P300 modulation, indicative of later general inhibition. 
Woodcock et al. 2010 [57] fMRI: set-shifting task. 
8 participants with PWS (5 males, mean 20.7 y) 
8 age & gender matched typically-developing control 
participants (mean 21 y) 
Control group showed increased activity compared to the PWS group in frontoparietal 
regions during switching, including in ventromedial PFC and posterior parietal cortex. 
PWS tended to show ventromedial PFC deactivation instead. 
Group interactions: Greater activity in hippocampus, amygdala, thalamus and putamen 
during switching in control group than PWS group, driven by deactivation of these areas 
by PWS group during switching alongside activation in the control group. The reverse 
pattern was found for the anterior poles. 
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Table 2. Cont. 
Study Methods Sample Mai findings 
Zhang et al. 2013 [58] Resting state fMRI 
21 participants with PWS (11 males, mean 7.3 y) 
18 sibling control participants (8 males, mean 11.1 y) 
ALFF greater in PWS than control group in ventrolateral PFC,ACC, inferior parietal 
lobe and left insula, and decreased in the medial and dorsolateral PFC, hippocampus, 
pre- and post-central gyri, and left OFC. 
DMN: reduced functional connectivity pairwise between medial PFC, inferior parietal 
lobe and precuneus, and between precuneus and inferior parietal lobe. 
PFC network: reduced functional connectivity between dorsolateral PFC and OFC, and 
increased functional connectivity between ventrolateral PFC and both OFC and 
dorsolateral PFC. 
Core network: increased ACC-insula functional connectivity. 
Motor sensory network: decrease pre- to post-central gyrus connectivity. 
Zhang et al. 2012 (see also 
2015) [59,60] 
Resting state fMRI 
21 participants with PWS  
(11 males, mean 7.3 y) 
18 sibling control participants  
(8 males, mean 11.1y) 
ALFF increased in PWS in ACC, hypothalamus, & left amygdala and decreased in 
medial PFC and right amygdala. 
Granger causality analysis of direction of connectivity: Increased causal influence 
bilaterally from amygdala to the hypothalamus, from the ACC to the medial PFC right 
amygdala, from the medial PFC to bilateral amygdala, & from ACC to medial PFC in 
PWS compared to control participants. Altered directionality in effective connectivity in 
all pairwise analyses except the right amygdala to hypothalamus, although this increased 
in strength. 
ACC: anterior cingulate cortex; ALFF: amplitude of low frequency fluctuation; AS: Angelman’s syndrome; BMI: body mass index; EEG: electroencephalography;  
ERP: event-related potential; fMRI: functional magnetic resonance imaging; ID: intellectual disability; m: months; OFC: orbitofrontal cortex; PET: positron emission 
tomography; PFC: prefrontal cortex; PWS: Prader-Willi syndrome; rCBF: regional cerebral blood flow; UPD: uniparental disomy; y: years.  
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Table 3. Studies reporting neurochemical investigations and neuroanatomy at the cellular level. 
 
Study Methods Sample Key findings 
Akefeldt et al. 1998 [61] 
Lumbar puncture: CSF analysed for 
metabolites of serotonin (5-HIAA), dopamine 
(HVA) & noradrenaline (HMPG) 
13 participants with PWS (8 males, 0.4–23 y) 
5 control groups: 15 typically-developing participants (11 males, 
6 aged 3–8 y, 9 aged 18–25 y); 22 typically-developing 
children (16 males, 3–14 y); 8 children with autism (5 
males, 3–13 y); 7 children with mixed neurological diagnoses (6 
males, 0.3–15 y); 4 overweight children with ID but not 
PWS (0 males, 4–15 y) 
Increased levels of 5-HIAA & HVA in PWS compared to all groups, most markedly  
for serotonin. 
Significant for 5-HIAA at corrected level compared to all control groups except the 
overweight and mixed neurological groups at the corrected significance level, but  
trend found. 
Significant for HVA at corrected level compared to typically-developing groups and 
all control participants combined. 
No association found between increased metabolites in PWS and age, BMI or 
severity of intellectual disability. 
Ebert et al. 1997 [62] Venepuncture: Plasma GABA levels 
14 participants with PWS (6 males, 2–21 y) 
9 children with AS (7 males, 2–17 y); 
2 control groups: 7 moderately obese participants without ID 
(5 males, 2–20 y); 5 healthy weight children with ID (4 
males, 3–17 y) 
Mean GABA levels in plasmas significantly higher (2-3 times) in both PWS and AS 
groups than either control group, but no significant difference between PWS and  
AS groups. 
Fronczek et al. 2005 [63]
Post-mortem: immunocytochemistry and 
image analysis system estimation of orexin 
neuron number in the lateral hypothalamus 
7 hypothalami from individuals with PWS (3 males, 5 adults 
aged 25–64 y, 2 infants aged 6m & 3 y) 
11 control hypothalami, matched for age, sex, post-mortem 
delay, fixation time and premorbid illness duration. 
No difference in number of orexin neurons in hypothalamus found. 
Goldstone et al. 2002 [64]
Post-mortem: immunocytochemistry & in situ 
hybridization to study NPY, AGRP, and NPY 
mRNA expression in the hypothalamus 
6 obese adults with PWS (2 males, 25–64 y) 
4 obese adults without PWS (2 males, 66–76 y) 
22 control adults (13 males, 28–90 y) 
Significant decrease of NPY and tendency to decreased NPY mRNA expression in all 
obese subjects, including PWS, but consistent with literature on inhibition on NPY  
in obesity. 
No significant difference in AGRP and NPY staining, or NPY mRNA expression, 
between PWS and obese adults without PWS. 
NPY/AGRP neurons show appropriate functioning. 
Goldstone et al. 2003 [65]
Post-mortem: immunocytochemistry 
assessment of GHRH neuron number in 
infundibular nucleus/median eminence 
complex of the hypothalamus 
6 adults with PWS (2 males, 25–64 y) 
2 children with PWS (1 males, 0.5 & 0.75 y) 
6 o6 control participants (13 males, 22 adults aged 28–90y,  
4 children aged 0.4–0.75 y) 
Higher GHRH neuron number in both control adults and adults with PWS who had 
prolonged premorbid illness, but no difference between PWS and control or obese 
adults without PWS. 
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Table 3. Cont. 
Study Methods Sample Key findings 
Hayashi et al.  
2011 [66] 
Post-mortem: immunohistochemical analysis 
of GABAergic interneurons in superior frontal 
cortex & OFC, ACh neurons in the nucleus 
basalis of Meynert & PPN, & orexin-A and 
vasopressin in the hypothalamus. 
6 month old female with PWS 
3 control subjects following fatal pneumonia (2 males, 4 m,  
1 y, 6 y) 
GABAergic interneurons in cortex and ACh neurons in nucleus basalis similar in 
PWS and control samples. 
No clear abnormalities in orexin and vasopressin neurons in hypothalamus. 
Marked reduction of ACh neurons in PPN. 
Lucignani et al.  
2004 [67] 
Resting state PET: 11C-flumazenil binding to 
evaluate GABAA receptor functioning. 
6 participants with PWS (2 males, 19.3–29.7 y, mean 24.6 y)
9 typically-developing participants (9 males, mean 25.9 y) 
Significant binding reduction (7%) in cingulate. 
Reduced binding of ca. 3-6% in PWS in temporal and frontal cortices, and including 
insula (7%), but not significant when corrected for multiple comparisons.  
Trend to reduced binding in amygdala, caudate and thalamus (10-14%). 
Binding potential very similar in hippocampus, putamen and parietal and  
occipital cortices. 
Martin et al. 1998 [68] 
Lumbar puncture: CSF analysed for levels of 
oxytocin and vasopressin 
5 participants with PWS (2 males, 16–21 y) 
6 typically-developing participants (0 males, 21–28 y) 
Oxytocin levels in CSF significantly higher in PWS, especially in females. 
Vasopressin levels significant lower in PWS females compared to control females, 
but not for males or combined sex groups. 
Pasi et al. 1989 [69] 
Post-mortem: immunoradiological assay of 
beta-endorphin levels in neural tissue 
19 y old female with PWS 
No clear beta-endorphin abnormality: rank of levels of beta-endorphin in areas of the 
brain on which there was prior reference literature (hypothalamus, medulla, 
periaqueductal grey, pons, & thalamus) was very similar, with the exception of  
the medulla. 
Swaab et al. 1995 [70] 
Post-mortem: thionine and 
immunocytochemical staining to assess PVN 
size and number of oxytocin and  
vasopressin neurons 
5 adults with PWS (2 males, 22–64 y) 
27 control adults (14 males) 
PVN significantly smaller (28%) in PWS, with total cell number reduced by 38%. 
Oxytocin number significantly decreased in PWS (by 42%) as was volume of PVN 
containing oxytocin cells (by 54%). 
No significant difference in number vasopressin neurons between PWS and  
control samples. 
Talebizadeh et al.  
2005 [71] 
Post-mortem: RT-PCR evaluation of gene 
expression of ghrelin, peptide YY and their 
receptors in the frontal, temporal, and visual 
cortices, pons, medulla and hypothalamus 
3 individuals with PWS (0 male, 1 infant aged 1 y, 2 adults 
aged 32 y) 
2 individuals with AS (4y old male, 43y old female) 
6 control individuals (3 males, 1–72 y) 
Expression detected in all brain areas in PWS, AS and control samples, with 
exception of PYY in pons for 1 PWS & 1 control subject. 
ACh: acetycholine; AGRP: agouti-related peptide; AS: Angelman’s syndrome; BMI: body mass index; CSF: cerebrospinal fluid; EMO: early-onset morbid obesity; GABA: 
gamma-aminobutyric acid; GHRH: growth hormone-releasing hormone; ID: intellectual disability; HMPG: 4-hydroxy-3-methoxyphenyl-ethylene glycol; HVA: 
homovanillic; m: months; mRNA: messenger ribonucleic acid; NPY: neuropeptid Y; OFC: orbitofrontal cortex; PET: positron emission tomography; PFC: prefrontal cortex; 
PPN: pedunculopontine nucleus: PVN: paraventricular nucleus; PWS: Prader-Willi syndrome; RT-PCR: reverse transcription polymerase chain reaction; UPD: uniparental 
disomy; y: years; 5-HIAA: 5-hydroxyindoleacetic acid. 
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Van Nieuwpoort et al. (2011) reported reduced anterior pituitary size in 12 adults with PWS 
compared to a control group, but no significant difference in posterior pituitary size nor absence of the 
pituitary bright spot [35]. Conversely, Miller et al. (1996) found no significant difference in the height 
of the anterior pituitary gland in 15 children with PWS compared to either isolated growth hormone 
deficiency or typically-developing controls, although approximately 20% showed no posterior pituitary 
bright spot [26]. Further, although Miller et al. (2006) described a higher rate of pituitary abnormalities 
in PWS compared to a typically-developing sibling control group, a similarly elevated rate was seen in 
early-onset morbid obesity group, questioning the specificity of pituitary abnormalities to PWS beyond 
early obesity more generally [30]. 
A further sizeable proportion of original research studies reporting anatomical neural findings in PWS 
were studies primarily concerned with characterising epilepsy in PWS. The majority of these studies 
involved retrospective case reviews of individuals with PWS attending particular services to ascertain the 
rate of epilepsy among these samples. With the exception of Gilboa and Gross-Tsur [16], only individuals 
presenting with seizures were further evaluated in regards to any anatomical abnormalities [15,20,25,34,36,37], 
thus largely confounding any assessment of the relationship between PWS and any anatomical 
irregularities found and the potential relationship to epilepsy. All studies reported the majority of 
individuals as presenting within normal limits according to their imaging evaluations, but where 
abnormalities were cited the most common were ventriculomegaly, agenesis of the corpus collosum and 
more general cortical atrophy [16,34,36,37]. The relationship of these abnormalities to the presence of 
epilepsy versus PWS is unclear and the general exclusion of individuals with PWS who don’t have 
seizures presents a major confound. However, the reported areas and types of abnormality are not 
dissimilar to those described in the wider PWS literature. 
Iughetti et al., (2008) also reported wider abnormalities in 10 of the 91 children in their study, namely 
ventriculomegaly in eight and thin corpus callosum in two [12]. A case series reporting neural 
investigations in four children with PWS following critical illness (three post-mortem, one MRI) found 
no clear consistent abnormalities; an array of varying neuropathologies in both grey and white matter in 
the cerebral cortex were described in three, including gyrification and corpus collosum neuropathology, 
as well as midbrain, hindbrain and cerebellar abnormalities in one case, while the fourth was within 
normal limits [33]. Other reports include a six month old with mild ventriculomegaly, poor cortical 
myelination (including corpus callosum) and cerebellar abnormalities, a male two-year old showing third 
and fourth ventricle expansion and hypoplasia of the corpus callosum, another male child (2.6 year) with 
cerebellar and corpus callosum abnormalities, and a female infant showing abnormal cerebral 
gyrification, including an abnormal sylvian fissure revealing part of the insula [18,39]. Hashimoto et al. 
(1998) also reported mild ventriculomegaly in four of five children with PWS, frontal cortical atrophy 
in three, and myelination delay in one, but no abnormalities of basal ganglia, thalamus, white matter and 
cerebellum [17]. Proton magnetic resonance spectroscopy indicated reduced N-acetylaspartate in two 
children, with decreases in this marker of neuronal functioning indicating neuronal loss or dysfunction. No 
neuropathologies were found in the comparison group of 37 typically-developing children of the same 
age range. However, Mantoulan et al., (2011) reported no clear structural abnormalities on the MRI 
scans of nine PWS teenagers (12.7 year-18.6 year) [24]. 
Considering the specificity of such abnormalities to PWS, Miller and colleagues published a series 
of analyses comparing participants with PWS to both typically-developing sibling controls and a group 
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of individuals with early-onset morbid obesity. Miller et al., (2006) reported white matter abnormalities 
in six of eight adults with PWS, varying in location and number but were most commonly in the 
orbitofrontal cortex [27]. However, none of the nine younger patients with PWS showed these lesions, 
nor did any of the typically-developing controls. Further, there were no significant differences between 
the presence, location or number of these neuropathologies between the PWS and early-onset obesity 
groups, with previous MRI scans for several patients in both groups indicating the later development of 
these abnormalities. Similarly, investigating cerebral and cerebellar volumes, Miller et al., (2009) 
reported smaller cerebellar volume and decreased cerebellar/cerebral ratios in both PWS and early-onset 
morbid obesity groups compared to typically-developing siblings, but no significant differences between 
them [31]. No differences between the three groups were found in cerebral volume. As described above, 
similar rates of pituitary abnormalities were also found in PWS and early-onset morbid obesity groups [30]. 
Consequently, these abnormalities would appear common in PWS, although non-specific and not 
universal, with early obesity a possible factor contributing to their development. 
Nevertheless, some such comparisons did suggest anomalies in the PWS brain not frequently seen in 
early onset morbid obesity. Miller et al., (2007) reported ventriculomegaly in all of 20 PWS participants, 
including infants for whom this was frequently the only abnormality present [29]. All participants over 
five years of age showed reduced parietal-occipital grey matter volume. Sylvian fissure polymicrogyria 
was reported in 60% and incomplete insular closure in 65%. No association with BMI or behavioural 
problems was found for any of these abnormalities and, with the exception of unilateral sylvian fissure 
polymicrogyria in two sibling and two early-onset obesity controls, these abnormalities were only seen 
in the PWS group. Looking more specifically at Sylvian fissure morphology in PWS, Miller et al. (2007) 
described incomplete closure of the insula in PWS compared to both a typically-developing sibling and 
early-onset morbid obesity control groups, with no significant differences between the control groups [28]. 
The closure of the insula is part of the process of cortical gyrification as the cortex develops [72], 
suggesting aberrant cortical development. However, in a comparison of cortical morphology in four 
children with PWS and six children with AS, Leonard et al. (1993) assessed the Sylvian fissure for 
abnormalities, measuring its features on MRI and qualitatively categorising each case, finding very few 
abnormalities in PWS, with many more in AS [21]. 
Larger quantitative assessment of cortical development is needed, rather than manual measurement 
and categorisation, to assess potential aberrant cortical gyrification more fully. Lukoshe et al., (2014) 
recently published one such study looking at gyrification in children with PWS [23]. Using quantitative 
MRI, Lukoshe and colleagues looked at the local gyrification index (the ratio between total brain surface 
area and the surface area of a local defined region) in children with PWS compared to age and sex 
matched siblings to assess cortical complexity in PWS, finding reduced cortical complexity in frontal, 
temporal and parietal lobes. In particular, there were differences between the local gyrification indices 
in four largely frontal clusters, including insula and cingulate areas, but also areas of the parietal and 
temporal lobes. Within the frontal clusters, there were moderate correlations of the local gyrification 
indices with IQ, although the strength and significance of such correlations differed across clusters and 
IQ scale (total, verbal and performance IQ). The authors note the previous reports of decreased 
gyrification with intellectual disability and suggest this indicates early deviations in brain development 
in PWS [73]. In a further analysis of this data, Lukoshe et al., (2013) described significantly smaller 
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brainstem volumes, and trends towards reduced white matter volume and total cortical surface area 
compared with the sibling control group [22]. 
A small number of other quantitative studies have also indicated abnormalities in both grey and white 
matter. Ogura et al., (2011) used voxel-based morphometry (VBM) to analyse MRI data from 12 participants 
with PWS compared to 13 age and gender-matched healthy-weight control participants, reporting an 
overall reduction in total brain tissue volume, grey matter volume and white matter volume, with specific 
reductions in the orbitofrontal cortex (OFC) and somatomotor areas [32]. Yamada et al., (2006) 
described abnormalities in frontal white matter, the posterior limb of the internal capsule and the 
splenium of the corpus callosum compared to age and gender-matched controls in a diffusion tensor 
imaging (DTI) study [38]. 
Differences between the genotypes have also been reported. Honea et al., (2012) reported a VBM 
analysis indicating smaller grey matter volume in the prefrontal and temporal cortices and reduced white 
matter volume in the parietal cortex in the deletion subtype, while those with UPD had smaller grey and 
white matter volume in orbitofrontal and limbic cortices [19]. However, those in the UPD group were, 
on average younger than those in the deletion group (mean 17.4 year vs. 25.2 year), which may present 
a confound owing to maturation of the brain, particularly of frontal regions, during this period of young 
adulthood. Lukoshe et al., (2013) reported increased ventriculomegaly in UPD compared to deletion as 
well as surface cerebrospinal fluid (CSF), suggesting increased atrophy or differential development in 
UPD in childhood [22]. Lukoshe et al., [23] additionally reported that two of the clusters in their findings 
had smaller local gyrification index values in participants with UPD compared to deletion, and that those 
with UPD had greater cortical thickness in one of these more frontal clusters. Contrasting neural structure 
between the genotypes and the relationship of any differences to those reported in the behavioural 
phenotype is understudied, perhaps owing to difficulties in recruiting adequate samples of those with UPD. 
Discussion of Anatomical Findings 
A considerable proportion of studies reporting anatomical abnormalities in the PWS brain were case 
studies or case series, including both neuroimaging and post-mortem evaluations. The single case 
qualitative nature of these reports clearly limits the generalisability of these findings, as does the 
presence of sudden death or critical illness in Stevenson et al.’s study [33]. The varying ages of the 
patients studied could be involved in the discrepancies described, owing to the different timings of 
maturational development across areas of the brain. Nevertheless, the case studies, despite their limited 
generalisability suggested abnormalities including ventriculomegaly, aberrant cortical gyrification and 
atrophy and corpus callosum and cerebellar abnormalities. Cerebellar abnormalities may be implicated 
in the hypotonia, while ventriculomegaly already present at such young ages may indicate abnormal 
development of the cerebral hemispheres and is often seen in genetic disorders associated with 
intellectual disability [29]. Reduced cortical gyrification has been also associated with cognitive 
difficulties and likely implicates atypical processes of neuronal development [73]. 
This is supported by studies of larger PWS samples, which have described diffuse areas of 
abnormality, including reports of possible reductions in total white matter and grey matter volume as 
well as total cortical surface area. More specifically, reported grey matter abnormalities include aberrant 
cortical gyrification largely of frontal cortex, but also extending to temporal and parietal areas, as well 
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as reduced grey matter in the orbitofrontal cortex and somatosensory areas. White matter atypicalities 
have been observed across frontal areas, as well as the large fibre bundles of the corpus callosum and 
the internal capsule. However, findings across studies are not always consistent and these reports need 
replication. Potential reasons for conflicting findings warrant further investigation, including between 
subtypes, clinical features and age, with many studies using participants spanning the lifetime from 
infancy through to middle-age, as well as the differing methodologies employed by each study. Many 
studies, including those describing multiple patients involved retrospective evaluations relying on 
previously acquired neuroimaging data, for which the contrasts used may differ widely, potential 
affecting the interpretation of findings across cases. However, many of the more systematic and 
controlled studies have also highlighted similar areas of neuropathology, including those where the 
image analysis was more quantitatively assessed without subjective or qualitative interpretation or 
categorisation by the researcher. 
The majority of these studies did not directly investigate the association of abnormalities with the 
phenotypic features of PWS. Nevertheless, most authors note the intuitive associations that can be drawn 
between the regions where abnormalities were noted and the common features of PWS. Brainstem 
abnormalities may be involved in the pain, sleep and respiration difficulties associated with PWS, 
cerebellar abnormalities may be implicated in the hypotonia, and cortical abnormalities, particularly of 
the frontal areas, may be involved in the intellectual disability and executive function deficits often seen 
in PWS. More direct assessment of potential associations between abnormalities of structure and the 
presenting PWS phenotype is warranted. 
4. Functional Studies in the PWS Brain 
4.1. Food-Related Function 
The majority of studies considering function in the PWS brain have investigated the overeating behaviour. 
These have highlighted dysfunction in neural networks involved in satiety and reward. Hinton et al., (2006) 
used positron emission tomography (PET) to investigate the neural response of 13 participants with PWS 
while viewing food images following an overnight fast, a 400 kcal meal and a 1200 kcal meal [43]. They 
observed a similar neural response to that seen in a previous study of healthy weight individuals without 
PWS when fasted, with activation of the hypothalamus, amygdala, basal ganglia, thalamus, anterior 
cingulate cortex (ACC) and lateral OFC. However, the neural response associated with satiety, including 
increased activity in the medial OFC, temporal cortex and prefrontal cortex (PFC) was not found, even 
after the 1200 kcal load. Importantly, Hinton et al., [43] were also able to demonstrate that the neural 
representation of satiety was not entirely absent: only half the participants showed a substantial change 
in ratings of fullness following the 1200 kcal meal, but in those who did there was a shift in increased 
activity from the lateral to medial OFC. Hinton et al., [43] suggested this shift may result from the reward 
system dissociations of these regions, with lateral OFC implicated in mediating punishment value and 
medial OFC in reward value, with the higher calorie meal leading to a more satisfied state for those 
reporting increased fullness. 
Similarly, Shapira et al., (2005) reported a significant delay after an oral glucose load in the neural 
response in brain areas implicated in satiety compared to a previous study with obese participants without 
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PWS and lean participants, at a mean latency of 24 min for the PWS participants, but only 15 and 10 min 
for the obese and lean participants respectively [54]. This only remained statistically significant for the 
ventromedial PFC when corrected for multiple comparisons, although the sample size was small (three 
participants). Miller et al., (2007) reported greater PFC activation in PWS compared to healthy control 
siblings during the postprandial phase following an oral glucose load, in particular significantly 
increased ventromedial PFC activity, when viewing pictures of food compared to pictures of animals or 
tools, suggesting this may represent an increased reward value of food in PWS [51]. 
A further analysis of Hinton and colleagues’ MRI data showed that the high or low incentive value 
of food items, as rated previously by the participants and stable over time, was not associated with altered 
activity in the amygdala or medial OFC [44]. These areas are typically involved in incentive motivation, 
suggesting that any incentive motivation typically driven by food preferences may be overridden by the 
lack of satiety. However, Dimitropoulos and Schultz (2008) observed a possible effect of preference, or 
at least calorie content, on food-related neural responses in PWS [41]. Following a fast of at least three 
hours, participants with PWS showed greater activity in the hypothalamus, amygdala, insula and OFC 
in response to highcalorie compared to low calorie images than a control group of mixed aetiology ID 
participants matched for IQ and BMI. 
Holsen et al. (2006) also used neuroimaging (fMRI) to look at the neural response to food images in 
PWS in areas implicated in reward and motivation; finding reduced activity in bilateral medial PFC and 
OFC in PWS when viewing food images in a pre-meal condition compared to a healthy weight control 
group, but increased activity in bilateral medial PFC, OFC and amygdala after a 500kcal meal [45]. 
Holsen et al. (2012) further described increased activation of the amygdala, hypothalamus and hippocampus 
in the PWS group compared to both healthy weight and obese control groups after a 500kcal meal, while 
the obese group exhibited greater activity in areas implicated in inhibitory control, including the 
dorsolateral PFC and the OFC [47]. Consequently, again, this study suggests that a combination of 
hyperactivity in regions implicated in food motivation and reward circuitry alongside hypoactivity in 
areas involved in inhibitory control may be responsible for the hyperphagia seen in PWS. 
Differences between the genetic subtypes in regards to the neural response concerning food have been 
described. Holsen et al. (2009) looking at the response to food images in nine deletion participants and 
nine UPD participants, found that the deletion group exhibited greater pre-meal activity in the medial 
PFC, insula and amygdala—areas implicated in reward and affective motivation [46]. Post-meal, the 
greater medial PFC activity exhibited by the deletion group persisted, suggesting continuing increased 
reward signalling when viewing food images. In contrast, the UPD group showed greater post-meal 
activity in the dorsolateral PFC and parahippocampal gyrus, suggesting the greater recruitment of higher 
order cognitive control networks in coordinating the post-meal neural response to food images. 
However, no differences between genetic subtypes were discernible using the Three Factor Eating 
Questionnaire (TFEQ [74]). Both groups showed increased activity both pre- and post-meal in areas 
implicated in food motivation compared to healthy weight controls. 
Consequently, the majority of studies investigating food-related functioning in the PWS brain have 
looked at the neural response to food images under different conditions of prior food intake. Both PET 
and fMRI evaluations suggest similar dysfunction, with subcortical areas implicated in motivation to eat 
showing prolonged or increased responding, while the responses inhibitory structures of the cortex 
appear to be delayed. 
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Investigating a different aspect of food motivation processing, Key and Dykens (2008) used EEG to 
look at neural discrimination of food composition and quality (single, combined in a palatable or 
unpalatable way or contaminated) between UPD, deletion and age-matched control groups [48]. Looking 
at the earlier N1 response, associated with perceptual characterisation, Key and Dykens found that those 
with deletion tended to process stimuli by quantity and those with UPD by quality, with controls more 
similar to those with UPD. The later P3 response, thought to reflect more cognitive motivational 
processing, indicated that those with deletion discriminated between palatable and unpalatable combined 
food stimuli, with response to the palatable stimuli greater than both the UPD and control group. This 
effect was present in the UPD group, although less pronounced, however this later event-related potential 
(ERP) was not present in the control group. The authors suggested that the reduced food motivation in 
controls may have prevented further processing of the images. EEG has greater temporal sensitivity, 
allowing the assessment of these very acute processes in a way that is not possible with imaging 
modalities such as PET and MRI. However, the ability to spatially localise any abnormalities is greatly 
reduced. The increase P3 response reported here may be related to the sustained motivation towards food 
images reported in the MRI and PET studies described above, with both genotypes showing greater 
dysfunction compared to controls. It is worth noting that both this EEG study and Holsen et al.’s [46] 
fMRI study comparing PWS genetic subtypes suggest that the deletion subtype may show greater 
atypicality, with those with UPD more similar to controls, although still dysfunctional. Combining these 
modalities within similar tasks may enable greater deconstruction of aberrant neural processing in both 
location and time. 
4.2. Function Relating to Other Aspects of the PWS Phenotype 
Atypical frontoparietal activation during set-shifting tasks has been postulated to underpin the need 
for routine and, by extension, temper outbursts, with Woodcock and colleagues reporting that a higher 
score on a questionnaire measure of repetitive behaviours positively correlated with severity of attention 
switching impairment during a computerized set-shifting task, as well as increased outburst-related 
behaviour exhibited during set-shifting and in response to unexpected change during more naturalistic 
activities [75–77]. In a matched-performance, cued task switching paradigm with eight individuals with 
PWS and eight typically-developing age and gender matched control participants, Woodcock et al., 
(2010) reported hypoactivity in frontoparietal regions, including the posterior parietal and ventromedial 
prefrontal cortices in the PWS group during switching [57]. The authors suggest this may relate to 
impairments in setting appropriate attentional weights as task rules shift. Woodcock et al. [57] also 
reported a group interaction effect with the hippocampus, amygdala, thalamus, and putamen exhibiting 
increased activation in the typically-developing group compared to the PWS group during switching. 
Activity in these areas did not differ significantly within the control group for switch compared to same 
task demands, with this difference arising due to the deactivation of these regions in the PWS group 
during switching. The PWS participants also failed to show the deactivation of areas in the bilateral 
frontal poles. Therefore, the authors suggest that, taken together, these findings may indicate a lack of 
activation of in the task-positive regions of the default mode network (DMN) and deactivation of  
task-negative areas, with dysfunction in this network previously associated with deficits in attentional 
control. Woodcock and colleagues propose that these difficulties with set-shifting underlie the 
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behavioural problems experienced by many people with PWS. Consequently, the research group has 
been investigating the use of “change cards” to flag up and prepare individuals for a change, in order to make 
the change more explicit and less unpredictable, reporting some improvement in behavioural response [78]. 
This does suggest that it is specifically unexpected change that is difficult in PWS, with more time to 
process a change enabling the individual to better respond to it. However, the predictability of changes 
was not directly tested in the cognitive tasks of set-shifting, where blocks of one task were followed by 
another after instruction regarding the change and thus the change was highlighted and not strictly 
unpredictable. Nevertheless, impairment in task performance was still found. Manipulating the 
predictability of switching in task runs may provide greater insight into the nature of this cognitive 
impairment in PWS, including the extent and type of preparation for change that may be most effective 
for reducing difficult behavioural antecedents. 
Other facets of cognition have also been considered in PWS. Using EEG, Stauder et al. (2002) looked 
at the P3 response to oddball tasks to investigate visual and auditory impairment in PWS [55]. The 
oddball usually evokes a positive P3 response that has maximal amplitude at central parietal electrode 
sites approximately 300 ms after the stimulus onset and is associated with memory processing and 
stimulus evaluation, with the amplitude particularly associated with depth of processing. Whilst the PWS 
group could perform the tasks, the P3 ERP amplitude was reduced compared to a healthy control group, 
with greater impairment in the auditory modality in PWS. The authors suggest that it may reflect short 
term memory deficits in PWS, based on previous findings of short term memory impairment in PWS 
and prior associations with the P3 ERP. Such impairment in working memory may not be independent 
from difficulties with set-shifting, which require stimuli to be monitored and different task sets to be 
kept online and reconfigured as appropriate. Deficits in working memory may impede the successful 
performance of such processes. Nevertheless, the poorer in the auditory modality suggests a particular 
impairment. Akefeldt et al., (1997) also reported potential auditory impairment, reporting possible 
abnormalities in the auditory brainstem response ERPs within their wider investigation of speech and 
language characteristics in PWS [40]. 
Some differences in the neural profiles of the UPD and deletion subtypes have been described in 
relation to aspects of the wider phenotype. Coding or processing speed has also been reported to differ 
between genotypes, being slower in those with UPD [79]. Neurophysiological evidence of this greater 
impairment in UPD comes from a study of ERPs during a go-nogo task [56]. While only the control 
group showed the both the typical N200 and P300 task modulation, related to early modality-specific 
inhibition and later general inhibition respectively, only the UPD group showed impaired late general 
inhibition alongside significantly poorer performance. As coding speed is also reported to be slower in 
both schizophrenia and vulnerability to the disorder [80,81], it is possible that this may be involved in 
the higher propensity of those with the UPD subtype to psychotic illness. 
The UPD subtype has also been associated with an increased prevalence of autism spectrum 
conditions and related behaviours (e.g.,[82]). Halit et al., (2008) investigated face processing in PWS, 
using EEG during face recognition and eye direction tasks, predicting that those with UPD would show 
greater deficits on these tasks of social cognition [42]. Behavioural scores were fairly poor, but did not 
differ between genotypes; however, the effects of face orientation and gaze direction on the N170 
amplitude did. Contrary to prediction, the N170 amplitude in the deletion, not UPD group, failed to 
differentiate upright from inverted faces and direct from averted gaze. This suggests impaired social 
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cognition in both groups with PWS, however the prediction of greater severity of dysfunction in UPD 
was not borne out.  
Subsequent to the literature search, but identified according to the criteria and updates from the 
databases initially searched, Klabunde et al., (2015) recently reported an fMRI study of skin picking in 
PWS [50]. The researchers compared the neural response during periods of picking to periods when no 
skin picking took place. Increased activity was observed in a number of areas during skin picking, 
including two clusters of activity; one in the right ACC and right middle frontal gyrus and the other 
encompassing the primary somatosensory cortex, supplementary motor area, left middle frontal gyrus 
and right insula. Activity in both the right insula and the left precentral gyrus correlated negatively with 
the number of current skin picking sites. Since these regions are implicated in the processes of 
interoception, movement, attention and somatosensation, and are also activated during pain processing 
and itching/scratching, the authors suggest that interoceptive dysfunction may lead to the skin picking 
behaviours in PWS, with the behaviour reinforced because it helps to maintain a balance in a system in 
which there is clear impairment (such as in the interoception of satiety and pain). 
4.3. Resting State 
Other researchers have looked at activity in the brain in PWS at rest, often correlating areas of aberrant 
activity with behavioural measures. Using PET, Mantoulan et al., (2011) analysed the regional cerebral 
blood flow (rCBF) in the absence of any task, reporting significant hypoperfusion in the limbic, superior 
temporal and parietal lobes, most strongly in the anterior cingulate and superior temporal regions, but 
also in the right orbitofrontal and postcentral gyri [24]. Moreover, significant associations were found 
between these areas and scores on the Childhood Behaviour Checklist, indicating the dysfunction found 
may be related to the social, behavioural and psychiatric disturbances. However, while the age range of 
this group of PWS participants was smaller than in many studies (12.7–18.6 y) the healthy control group 
were generally older (mean 21.2 y), presenting a potential confound given the rapid neural development 
expected at this time. 
Kim et al., (2006) [49] studied regional glucose metabolism using fludeoxyglucose (18F) PET in 
children with PWS, including those at the transitional phase between failure to thrive and overeating, 
compared to typically-developing relatives, following a fast of at least four hours [49]. In those with PWS, 
Kim et al., [49] reported decreased metabolism in the right superior temporal gyrus, left verebellar 
vermis, right OFC, right temporal pole and left uncus. Increased metabolism was observed in the bilateral 
middle frontal cortex, left superior frontal cortex and right inferior frontal cortex, as well as the ACC. 
The authors note that these regions have all been implicated either directly or indirectly with cognition 
relating to eating, taste and food reward, emotion, and obsessive-compulsive behaviours, but these 
behaviours and skills were not directly measured. This finding of increased metabolism in the ACC 
contrasts with the hypoperfusion, particularly of the ACC and superior temporal regions, reported by 
Mantoulan et al., [24] who suggest that the use of sedation in the current study may have contributed to 
this discrepancy. Other possible factors include the difference in mean age of the children in each study 
(4.2 y in Kim et al. [49] vs. 16.4 y in Mantoulan et al. [24]), with Kim et al. [49], reporting the inclusion 
of children at the transitional eating phase, as well as the fact that participants in Kim et al.’s [49] study 
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had fasted prior to the scan and thus may have been in a different motivational state to those in Mantoulan 
et al.’s [24] study. 
Ogura et al., [52] studied regional rCBF at rest using single proton emission computed tomography 
(SPECT) in the same 12 participants and age-matched controls who participated in their anatomical MRI 
study described above [32]. Reduced rCBF was reported bilaterally in the lingual gyri and cerebellum 
and in the right thalamus and left insula, whilst increased rCBF was found bilaterally in the angular gyri 
and inferior frontal gyri and in the left middle frontal gyrus. In this study, a questionnaire assessing 
eating, stereotyped and collecting/hoarding behaviour was administered, with the eating severity score 
correlating negatively with rCBF in the left insula—an area associated with conscious interoception of 
internal states. These participants with PWS were older than those in either Kim et al. [49] or Mantoulan  
et al.’s [24] studies, but closer in age to the latter and, similarly, remained unsedated during the scan. The 
findings bear some similarity to those of both prior studies, but appear to show greater consistency with 
those of Kim et al., [49] suggesting neither sedation nor age may be the main explanatory variable. 
Perhaps crucially, the participants taking both Ogura et al. [52] and Kim et al.’s [49] study were fasted, 
whilst Mantoulan et al., [24] do not report a fasted state in their protocol. 
Considering how alterations in distinct neural areas may lead to network dysfunction, Zhang et al. 
(2013) studied functional connectivity in 21 children with PWS using resting-state fMRI in four resting 
state networks (RSNs) encompassing regions implicated in eating behaviour: the DMN, the core 
network, the prefrontal lobe network and the sensorimotor network [58]. The authors ascertained regions 
of interest (ROIs) by identifying regions which showed significant differences in activity at rest between 
the PWS participants and a healthy sibling control group. Increased amplitude of low frequency 
fluctuation (ALFF) was reported in the PWS group compared to the control group in the bilateral 
ventrolateral PFC, ACC, inferior parietal lobe and left insula, while decreased ALFF was found 
bilaterally in the medial and dorsolateral PFC, hippocampus, precuneus, and pre- and post-central gyri, and 
the leftOFC. This largely supports Kim et al.’s [49] findings of increased rCBF in the ACC, but contrasts 
with Ogura et al.’s [52] reports of decreased activity in the insula and both studies accounts of increased 
medial PFC activity. Again, the difference in conditions of fasting may be implicated. 
The pairwise functional connectivity strengths between these regions were analysed within the four 
RSNs of interest. All networks showed alterations in functional connectivity. Within the DMN there was 
reduced functional connectivity strength between the inferior parietal lobe and the medial PFC, precuneus 
and hippocampus, as well as between the medial PFC and precuneus, echoing Woodcock et al.’s [57] 
findings of aberrant recruitment of frontoparietal areas during set-shifting. In the sensorimotor network 
decreased functional connectivity between the pre and post central gyri was reported. The prefrontal 
cortex network showed reduced connectivity strength between the dorsolateral PFC and OFC, but 
increased strength between the ventrolateral PFC and the OFC and dorsolateral PFC. Increased 
functional connectivity strength was also observed between the ACC and the insula in the core network. 
The authors related these differences to differences in reward and food regulation processing in PWS, 
with these areas frequently found to show aberrant activity in the studies in which participants viewed 
food images (see 4.1). However, no direct measures of eating behaviour in these participants were taken, 
nor were the findings considered in light of other PWS characteristics. 
Zhang et al., (2012) [59]; also published as a full length article subsequent to the literature search [60] 
took this analysis further, assessing the directionality of causal influence in functional connectivity using 
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Granger causality analysis, using the medial PFC, ACC, amygdala, and hypothalamus as ROIs based on 
their previous implication in the aberrant eating behaviour in PWS . They reported increased ALFF in 
the ACC, hypothalamus and left amygdala, with decreased ALFF in the medial PFC and right amygdala; 
again, these are areas typically highlighted by studies using a food image viewing task and strongly 
implicated in food-related motivation. Zhang and colleagues reported increased Granger causality 
bilaterally from the amygdala to the hypothalamus, from the ACC to right amygdala, from medial PFC 
to bilateral amygdala, and from ACC to medial PFC in PWS. Furthermore, altered directionality in 
effective connectivity was found between all pairwise combinations of these ROIs, with the exception 
of the right amygdala to the hypothalamus in which directionality was the same as the control group but 
markedly increased in strength. The authors argue that this shows abnormal connectivity and strength of 
the “driving force” in food-related circuitry at rest in PWS, which appears to involve widespread atypical 
functioning across a distributed network. Although not considered in the study, these areas are also 
implicated in emotional cognition and regulation and may also indicate aberrant network activity 
involved in other features of PWS, such as mood lability and related maladaptive behaviours. 
Resting state neuroimaging presents advantages, particularly in patient populations who may not be 
able to adequately complete tasks or whose performance may differ so greatly to controls as to be 
incomparable, however it does not come without its limitations. In particular, functional connectivity 
has been criticised for susceptibilty to motion artefacts. Pujol et al., (2014) studied the effects of motion 
in resting state fMRI in children, young adults, older adults, PWS, Down’s syndrome and William’s 
syndrome [53]. In young adults (the group who moved least), motion correlated with connectivity in a 
system-specific way, showing positive correlations in sensorimotor cortex and visual areas but 
negatively with areas of the DMN, likely reflecting neural function related to the motion rather than 
actefactual error. Different regions were found to correlate with motion in each developmental disorder, 
with motion in PWS mainly correlated with frontal and temporal basal regions, including the 
hypothalamus, but also with the dorsal ACC. The authors assert the need to consider carefully not only 
motion effects on connectivity but also the effects of correcting for them, particularly as these may differ 
according to extent of motion and disorder and may be distinct according to disorder. 
4.4. Discussion of Functional Findings 
Research to date is weighted towards exploration of the prominent hyperphagia seen in PWS, with 
studies describing a significantly delayed satiety response, with aberrant activity in areas associated with 
reward and motivation and many of the resting state findings interpreted in light of the eating behaviour 
only. In comparison to food-related neural function, mechanisms underlying the further cognitive, 
behavioural and psychiatric features have been less researched and are currently poorly understood. 
Briefly, hyperactivity of regions associated with reward or motivation, such as the hypothalamus and 
amygdala, and hypoactivity of regions implicated in inhibitory control (typically frontal cortex) are 
typically observed during food-related tasks. Hypoactivity was also described in Woodcock et al.’s [57] 
work investigating attention switching in PWS, with frontoparietal areas failing to be adequately 
recruited, and increased activity in areas of the DMN, which includes the hippocampus, medial PFC and 
other areas which remained hyperactive in the food-based functional reports. Studies of the brain at rest 
in PWS have reported aberrant activity most notably in similar areas to those implicated in the  
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task-based studies, including the ACC, medial PFC, OFC, dorsolateral PFC, thalamus, insula, 
hippocampus and hypothalamus, as well as in regions of the parietal and temporal lobes. This suggests 
widespread dysfunction across distributed neural circuits, supported by Zhang et al.’s [58–60] findings 
of altered connectivity strength between these areas, including between subcortical and cortical areas, which 
may be involved in the balance of subcortical motivational drive states and cortical integration of  
such information. 
5. Neurochemical Investigations and Neuroanatomy at the Cellular Level 
Other studies have focused on potential neurochemical abnormalities in PWS. Swaab et al., (1995) 
reported a decrease in the size of the paraventricular nuclei (PVN) of the hypothalamus in five 
individuals with PWS compared to 27 control PVN samples [70]. This reduction corresponded to a 
significantly and marked reduction in the number of oxytocin-expressing neurons in PWS as well as the 
volume of the PVN containing them, but no significant difference in the number of vasopressin cells. 
Oxytocin is known to play a role in inhibition of eating behaviour as well as social behaviour and the 
reduction anxiety and related arousal [83,84], and thus may explain to some extent the combination of 
behaviours in PWS. Conversely, however, Martin et al. (1998) reported increased levels of oxytocin in 
the CSF of five individuals with PWS compared to six control participants, especially in females [68]. 
Vasopressin levels did not differ significantly between the PWS and control groups, except when split 
by gender, when vasopressin levels were significantly reduced in PWS females compared to control 
females. The PWS participants were younger (16–21 y) than the control participants (21–28 y), which 
presents a potential confound. Nevertheless, both studies suggest dysfunction of the oxytocin system in 
PWS, and it is important to note the ability for both upregulation and downregulation of activity in 
impaired systems. 
Dysfunction of neurochemical systems in PWS is also unlikely to be specific to the oxytocin system with 
Akefeldt et al. (1998) reporting increased serotonin and dopamine metabolites in the CSF in PWS compared 
to a number of healthy and disorder control groups combined, most significantly for serotonin [61]. When 
compared separately to the overweight group and mixed intellectual disability groups this was not 
significant, and may indicate a role for weight and ID rather than specifically the presence of PWS. 
However, no association between the metabolite levels and BMI or IQ was found, and a significant 
difference was seen between the PWS group and a group with autism including low IQ. Moreover, the 
overweight group, in particular, was very small, meaning there may have been little power to detect a 
significant difference; a trend in the right direction was found. 
Lucignani et al., (2004) investigated gamma-aminobutyric acid (GABA) A receptor function in six 
young adults PWS compared to typically-developing control participants using resting-state positron 
emission tomography of the benzodiazepine binding site (carbon-11 flumazenil binding), since the genes 
encoding three GABAA receptor subunits are found within the PWS critical region [67]. ROI analyses 
found reduced binding in frontal and temporal cortices, notably in the insula and cingulate cortex, 
although only the cingulate was significant after correction for multiple comparisons. Trends towards 
reduced binding were also seen in the amygdala, caudate nucleus and thalamus, while binding in the 
parietal and occipital cortices, hippocampus, and putamen were similar to that in typically-developing 
controls. This suggests aberrant GABAergic function in PWS in both frontal and limbic cortical areas, 
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as well as subcortical regions. Ebert et al., (1997) also reported evidence for GABAergic dysfunction 
using plasma GABA levels as a proxy for CNS levels, reporting plasma GABA levels 2-3 times higher 
in both PWS and AS compared to both obese controls without ID and healthy weight controls with ID 
of mixed aetiology [62]. A better understanding of the relation of this finding to reduced binding in 
Lucignani et al.’s [67] study would require further measurement of GABA levels within the central 
nervous system. 
Single case post-mortem studies have also reported potential neurochemical dysfunction. Hayashi et al. 
(2011) reported a reduced number of acetylcholine neurons in a six-month old female compared to three 
controls in the pedunculopontine nucleus, with no significant difference in the number of acetylcholinergic 
neurons in the basal nucleus of Meynert, GABAergic interneurons in the cerebral cortex, nor vasopressin 
and orexin-A neurons in the hypothalamus [66]. The authors suggested a potential role of the 
acetylcholine neurons of the pedunculopontine nucleus in the sleep dysregulation and hypotonia seen in 
PWS, while the findings regarding vasopressin support the work of Swaab et al. [70]. The lack of 
GABAergic dysfunction reported here may result from the differering aspects of the GABAergic system 
studied (e.g., interneurons in this case in contrast to receptors or plasma levels). However, other authors 
have failed to find abnormalities, despite intuitive associations between particular neurochemicals and 
features of PWS. In line with Hayashi et al.’s [66] results, an earlier study by Fronczek et al., (2005) 
also observed no significant difference in orexin neurons in the hypothalami of seven PWS patients 
compared to well-matched control samples (matched for age, sex, post-mortem delay, fixation time and 
premorbid illness duration), suggesting orexin is not directly implicated in the hypersomnolence seen in 
PWS [63]. Goldstone et al., (2002) reported similar NPY and AGRP staining and NPY mRNA 
expression in the post-mortem hypothalami of six obese PWS patients compared to obese controls, 
although NPY and NPY mRNA expression was significantly reduced compared to healthy weight 
controls compared to all obese subjects [64]. This was consistent with the literature about effects of 
obesity on these peptides and was not present in two infants with PWS prior to hyperphagia and obesity 
onset (unpublished data reported in [64]), suggesting that NPY/AGRP neurons function appropriately in 
PWS, and any deviance from normative levels can be accounted for by factors such as obesity. In another 
post-mortem study, Goldstone et al., (2003) also found no evidence for abnormal growth-hormone-
releasing hormone neuron numbers in PWS, suggesting a reduction in neurons is not the primary cause 
of the growth hormone deficiency [65]. 
Talebizadeh et al., (2005) looked at the expression of ghrelin and peptide YY and their receptors in 
post-mortem samples of six brain regions (frontal, temporal and visual cortices, and pons, medulla and 
hypothalamus) in three PWS patients and six control samples finding qualitatively similar expression in 
all samples, although a quantitative (and preliminary) analysis of expression levels was only carried out 
for the 1 y old PWS and control samples suggesting potential quantitative growth hormone receptor 
difference [71]. Finally, Pasi et al., (1989) [69] reported no clear alterations of beta-endorphin levels 
pertaining to PWS in a single case post-mortem study of a young female adult with PWS, despite 
literature suggesting an association between beta-endorphin increases in CSF and appetite, pain 
insensitivity and thermoregulation difficulties [69].  
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Discussion of Neurochemical Findings 
Dysfunction in PWS appears unlikely to be specific to a singular neurochemical system, with 
abnormalities in a variety of diffuse neurochemical systems described to date. Some researchers have 
conducted anatomical investigations of cellular number, while others have looked at levels of 
neuropeptides or their metabolites. Replication of findings is clearly required, with a relatively small 
number of studies largely focusing on differing systems, and seemingly conflicting findings when the 
same system has been studied by different methods, such as post-mortem vs. in vivo, or when different 
aspects of the same system have been considered. However, dysfunction across the monaminergic, 
cholinergic and oxytocin systems in PWS seems probable. Further investigation of GABA dysfunction 
may be especially warranted, given the observations detailed above and the location of GABA receptor 
genes within the PWS region, although these are not thought to be imprinted. GABAergic dysfunction 
is believed to play an important role in psychiatric disorders, including psychosis [85,86], and may be 
involved in the high propensity to psychiatric illness seen in PWS. 
6. General Discussion 
Given the range of disturbances exhibited in the PWS phenotype, it seems likely that PWS involves 
aberrant activity across distributed neural networks and diffuse neurochemical systems. Research to date 
suggests that a combination of subcortical and higher cortical structures are involved, including those 
involved in processing reward, motivation, affect and higher order cognitive functions, with both 
anatomical and functional investigations indicating abnormalities. However, at present, characterisation 
of neural structure and function in PWS warrants replication and further systematic study. Given reports 
of atypical cortical gyrification, it is plausible that aberrant processes begin very early, possibly during 
the period of neuronal differentiation and migration. Preliminary evidence of differences in 
neuropathology and function between the two major PWS genetic subtypes is also available, which may 
be involved in corresponding variations in the expressed phenotype. Consequently, careful evaluation 
of connectivity in the PWS brain may prove fruitful in gaining inside into the pathway from PWS 
genetics to cognition and behaviour. In doing so, drawing on knowledge of networks and neural regions 
implicated in particular functions, including cognitive control, motivation, reward and affect, for 
example, will be essential. 
In particular, the limbic cortico-striatal-pallido-thalamic loops, involving the orbitomedial prefrontal 
cortex, anterior cingulate cortex, ventral striatum, ventral pallidum and thalamus, with inputs from the 
hippocampus and amygdala appear to be implicated in emotional cognition, regulation and lability, 
modulated by the diffuse neurochemical systems [87,88]. A further potentially relevant network is the 
dorsolateral prefrontal network which has been strongly associated with executive functions, including 
the set-shifting ability reported to be impaired in PWS. The dorsolateral prefrontal network has 
connections with premotor and parietal regions and projects to caudate head, pallidum and thalamus, 
with inputs from premotor and parietal regions in the case of the former [87,88], with frontopariental 
activity reported to be aberrant during set-shifting in PWS [57].  
In PWS, it appears likely that the difficulties with emotional regulation and the outburst behaviours 
may be associated with abnormalities in this circuitry. Many of these are areas which do appear to have 
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been most consistently implicated in the literature regarding neural structure and function in PWS, 
whether anatomical, function during tasks or at rest. They have also been implicated to varying extents 
in the aetiology of disorders with which PWS shares some features, including depression and mood 
control, anxiety, obsessive-compulsive disorder, impulsive aggression (as differing from premeditated 
violence), and deficits in executive function [87–95]. 
Damage to the orbitomedial PFC has long been associated with deficits in emotional and impulse 
processing and regulation and use of emotional information in decision; for example, Damasio and 
colleagues’ findings that lesions to this area led to an absence of the automatic visceral response to 
emotive stimuli alongside an inability to take into account long-term consequences of actions (e.g., [96]). 
The interplay between central and autonomic nervous systems in regulating coordinated behavioural 
responses is considered in Porges’ polyvagal theory [97], which sees alteration of vagal tone as crucial 
in coordinating and integrating physiological and neural processes to form appropriate behavioural 
responses from the basic flight/flight reactions to more nuanced socially aware interactions. Importantly, 
this theory proposes that flexibility of behavioural responses crucially involves heart rate variability. 
Associations of activity in ventromedial PFC, an area repeatedly highlighted in this article, and cardiac 
function, via efferent vagal projections, have been reported [98]. Our group recently described 
preliminary reports of improvement of PWS-associated behaviours, with increased behavioural 
flexibility in an open trial of vagus nerve stimulation [99], potentially implicating this complex interplay 
in the maladaptive behaviours seen in PWS, with VNS demonstrated to influence activity throughout 
the brain, including the hypothalamus, OFC, amygdala, hippocampus, insula, medial PFC and cingulate 
cortex [89,100]. 
Consideration of neural networks in other disorders which appear to share some of the behavioural 
features associated with PWS and have already undergone more systematic neural investigation may 
provide a framework for investigation in a similar way to the application of research on food motivation 
and eating behaviour in healthy populations to the PWS population. 
7. Conclusions 
Much of the research on neural structure and function in PWS concern the prominent overeating 
behaviour seen in the disorder, with other features of PWS much less well defined at this level, often 
with only a singular study per feature. Anatomical abnormalities have been more extensively considered, 
although only more recently using the more quantitative techniques which have become available in 
neuroimaging with technological advances. The anatomy and function of the brain in PWS has also 
rarely been studied within the same samples. Nevertheless, across methodologies and designs, functional 
and anatomical studies have implicated a combination of subcortical and higher order structures in PWS, 
including those involved in processing reward, motivation, affect and higher order cognitive functions, 
potentially influenced by abnormalities in diffuse neurochemical systems. Further consideration of the 
specificity of abnormalities to PWS and their relation to the features and behaviours associated with the 
syndrome will be crucial in increasing our understanding of PWS and the development of  
therapeutic strategies.  
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